Literature DB >> 8940088

Active repression of major histocompatibility complex class I genes in a human neuroblastoma cell line.

C Murphy1, D Nikodem, K Howcroft, J D Weissman, D S Singer.   

Abstract

Human neuronal cells express neither major histocompatibility complex (MHC) class I RNA nor cell surface molecules but can be induced to do so by various cytokines. In the present studies, we report that expression of MHC class I in a neuroblastoma cell line, CHP-126, is actively repressed. This repression is mediated by the combined effects of a series of upstream silencer elements. Removal of the silencers reveals not only an active promoter element but also the presence of an active enhancer. Four silencers have been identified and shown to have distinct sequences, binding factors, and patterns of function. One element is located between -724 and -697 base pairs (bp) and corresponds to a silencer involved in tissue-specific regulation of class I gene expression. Three additional elements occur between -503 and -402 bp. One of these corresponds to a c-jun responsive element. Neither of the remaining elements corresponds to DNA sequences known to regulate expression of other genes. These data demonstrate that MHC class I expression normally is actively repressed in neuronal cells and suggest a model of rapid and specific triggering of class I in neuronal cells in response to infection.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8940088     DOI: 10.1074/jbc.271.48.30992

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Histone modifications, but not nucleosomal positioning, correlate with major histocompatibility complex class I promoter activity in different tissues in vivo.

Authors:  Aparna S Kotekar; Jocelyn D Weissman; Anne Gegonne; Helit Cohen; Dinah S Singer
Journal:  Mol Cell Biol       Date:  2008-09-22       Impact factor: 4.272

2.  Control of cell cycle progression by c-Jun is p53 dependent.

Authors:  M Schreiber; A Kolbus; F Piu; A Szabowski; U Möhle-Steinlein; J Tian; M Karin; P Angel; E F Wagner
Journal:  Genes Dev       Date:  1999-03-01       Impact factor: 11.361

3.  Upstream stimulatory factor regulates major histocompatibility complex class I gene expression: the U2DeltaE4 splice variant abrogates E-box activity.

Authors:  T K Howcroft; C Murphy; J D Weissman; S J Huber; M Sawadogo; D S Singer
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

4.  Complicated mechanisms of class II transactivator transcription deficiency in small cell lung cancer and neuroblastoma.

Authors:  Takuya Yazawa; Takaaki Ito; Hiroshi Kamma; Takehisa Suzuki; Koji Okudela; Hiroyuki Hayashi; Hisashi Horiguchi; Takesaburo Ogata; Hideaki Mitsui; Masaichi Ikeda; Hitoshi Kitamura
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

5.  Distinct transcriptional pathways regulate basal and activated major histocompatibility complex class I expression.

Authors:  T Kevin Howcroft; Aparna Raval; Jocelyn D Weissman; Anne Gegonne; Dinah S Singer
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

6.  Hormonal Regulation of the MHC Class I Gene in Thyroid Cells: Role of the Promoter "Tissue-Specific" Region.

Authors:  Cesidio Giuliani; Sara Verrocchio; Fabio Verginelli; Ines Bucci; Antonino Grassadonia; Giorgio Napolitano
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-06       Impact factor: 5.555

7.  In vivo expression of MHC class I genes depends on the presence of a downstream barrier element.

Authors:  Helit Cohen; Palak Parekh; Zeynep Sercan; Aparna Kotekar; Jocelyn D Weissman; Dinah S Singer
Journal:  PLoS One       Date:  2009-08-26       Impact factor: 3.240

Review 8.  Role of Human Leukocyte Antigen System as A Predictive Biomarker for Checkpoint-Based Immunotherapy in Cancer Patients.

Authors:  Francesco Sabbatino; Luigi Liguori; Giovanna Polcaro; Ilaria Salvato; Gaetano Caramori; Francesco A Salzano; Vincenzo Casolaro; Cristiana Stellato; Jessica Dal Col; Stefano Pepe
Journal:  Int J Mol Sci       Date:  2020-10-02       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.